Skip to main content
. 2018 Sep 4;9:799. doi: 10.3389/fphar.2018.00799

Table 3.

Effects of PrEP on condom use.

Study name Outcome Description
RCTS: PrEP vs. NO PrEP
CDC safety study CAS CASPU
  • CAS: no statistical difference between immediate vs. delayed arms during months 3–9 (p = 0.10) and no significant change when delayed group initiated study drug 0.42)

  • CASPU: remained stable or decreased [2.02 at baseline vs. 1.51 during months 3–9 (p = 0.22) and 2.02 at baseline vs. 1.37 during months 12–24 (p = 0.05)]

iPrEx study Percent of receptive anal partners with which condoms used
  • No significant treatment by visit interaction (p = 0.36) with 50.38% in TDF-FTC and 51.04% in placebo at baseline plus 73.98% in TDF-FTC and 83.64% in placebo at follow-up

Project PrEPare CAS
  • No significant differences among the 3 treatment groups across visits; Insignificant trend from baseline to week 24 of decreasing condomless anal sex across all treatment arms.

Ipergay CAS
  • No significant differences in the total number of episodes of sexual intercourse in the 4 weeks before visits (p = 0.07), in the proportion of episodes of CRAS (p = 0.40), or in the proportion of episodes of CAS during the most recent sexual intercourse (p = 0.90) across groups.

OBSERVATIONAL STUDIES: CHANGE DURING PrEP USE or COMPARISON BETWEEN PRE/POST PrEP
iPrEx OLE CAS
  • Decreased from 34% (377/1115) to 25% (232/926) among PrEP recipients (p = 0.006), and from 27 (101/369) to 20% (61/304) among non-recipients (p = 0.03).

  • Decreases in CRAS and CIAS were similar across groups (p = 0.95 and p = 0.56).

Ipergay OLE CAS at the last sexual intercourse
  • CAS: significant increase from 77%(136/176) at baseline to 86%(66/76) at 18 months' follow-up (p = 0.004)

KPSF Condom use
  • Condom use: unchange in 56% of PrEP users, decrease in 41% of PrEP users, and increase in 3% of PrEP users

NCT01632995 CAS
  • CAS:baseline:165/557(65.5%);remained stable (65.6%) during follow-up (p = 0.99)

PATH-PrEP CAS
  • CAS: decreased over the first 24 weeks of study, and then were stable thereafter

CAS, condomless anal sex; CASPU, condomless anal sex with HIV positive/unknown status partner; CRAS, condomless receptive anal intercourse; CIAS, condomless insertive anal intercourse; PY, person-years.